Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Gottschalk

Showing results (51-60 of 227) with videos related to

Pageof 23
Sort By:
Immunological Reviews|December 17, 2013
Design and development of therapies using chimeric antigen receptor-expressing T cellsGianpietro Dotti, Stephen Gottschalk, Barbara Savoldo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2026
T cell Engineer: An interactive website to track CAR T cell negative regulatorsMeghan B Ward, Hongbo Chi, Stephen Gottschalk, et al.
Nature Immunology|July 18, 2024
T cell dysfunction and therapeutic intervention in cancerCaitlin C Zebley, Dietmar Zehn, Stephen Gottschalk, et al.
Frontiers in Oncology|January 16, 2014
Genetically modified T cells to target glioblastomaSimone Krebs, Tania G Rodríguez-Cruz, Christopher Derenzo, et al.
Cancers|September 10, 2021
Cytolytic Activity of CAR T Cells and Maintenance of Their CD4+ Subset Is Critical for Optimal Antitumor Activity in Preclinical Solid Tumor ModelsMarianna Csaplár, János Szöllősi, Stephen Gottschalk, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2016
EBV-Directed T Cell Therapeutics for EBV-Associated LymphomasLauren P McLaughlin, Stephen Gottschalk, Cliona M Rooney, et al.
Cancers|December 23, 2023
Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for GlioblastomaKristen D Pawlowski, Joseph T Duffy, Stephen Gottschalk, et al.
Molecular Therapy. Methods & Clinical Development|March 20, 2018
Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of GliomaZhongzhen Yi, Brooke L Prinzing, Felicia Cao, et al.
Oncoimmunology|December 3, 2021
Unifying heterogeneous expression data to predict targets for CAR-T cell therapyPatrick Schreiner, Mireya Paulina Velasquez, Stephen Gottschalk, et al.
The Lancet. Oncology|October 2, 2013
Is cancer gene therapy an empty suit?Malcolm K Brenner, Stephen Gottschalk, Ann M Leen, et al.
Pageof 23

Showing results (51-60 of 227) with videos related to

Sort By:
Pageof 23
Immunological Reviews|December 17, 2013
Design and development of therapies using chimeric antigen receptor-expressing T cellsGianpietro Dotti, Stephen Gottschalk, Barbara Savoldo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2026
T cell Engineer: An interactive website to track CAR T cell negative regulatorsMeghan B Ward, Hongbo Chi, Stephen Gottschalk, et al.
Nature Immunology|July 18, 2024
T cell dysfunction and therapeutic intervention in cancerCaitlin C Zebley, Dietmar Zehn, Stephen Gottschalk, et al.
Frontiers in Oncology|January 16, 2014
Genetically modified T cells to target glioblastomaSimone Krebs, Tania G Rodríguez-Cruz, Christopher Derenzo, et al.
Cancers|September 10, 2021
Cytolytic Activity of CAR T Cells and Maintenance of Their CD4+ Subset Is Critical for Optimal Antitumor Activity in Preclinical Solid Tumor ModelsMarianna Csaplár, János Szöllősi, Stephen Gottschalk, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2016
EBV-Directed T Cell Therapeutics for EBV-Associated LymphomasLauren P McLaughlin, Stephen Gottschalk, Cliona M Rooney, et al.
Cancers|December 23, 2023
Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for GlioblastomaKristen D Pawlowski, Joseph T Duffy, Stephen Gottschalk, et al.
Molecular Therapy. Methods & Clinical Development|March 20, 2018
Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of GliomaZhongzhen Yi, Brooke L Prinzing, Felicia Cao, et al.
Oncoimmunology|December 3, 2021
Unifying heterogeneous expression data to predict targets for CAR-T cell therapyPatrick Schreiner, Mireya Paulina Velasquez, Stephen Gottschalk, et al.
The Lancet. Oncology|October 2, 2013
Is cancer gene therapy an empty suit?Malcolm K Brenner, Stephen Gottschalk, Ann M Leen, et al.
Pageof 23